X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (228) 228
Publication (15) 15
Newspaper Article (14) 14
Dissertation (4) 4
Patent (4) 4
Conference Proceeding (2) 2
Government Document (2) 2
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (84) 84
index medicus (79) 79
male (70) 70
female (67) 67
oncology (63) 63
aged (59) 59
middle aged (50) 50
chemotherapy (42) 42
lung neoplasms - drug therapy (41) 41
carcinoma, non-small-cell lung - drug therapy (34) 34
lung cancer (33) 33
adult (27) 27
aged, 80 and over (27) 27
antineoplastic combined chemotherapy protocols - therapeutic use (27) 27
cancer (24) 24
lung neoplasms - mortality (24) 24
care and treatment (23) 23
docetaxel (23) 23
lung cancer, non-small cell (23) 23
non-small cell lung cancer (20) 20
animals (19) 19
carcinoma, non-small-cell lung - mortality (19) 19
cisplatin (19) 19
lung neoplasms - pathology (19) 19
disease-free survival (18) 18
prognosis (18) 18
treatment outcome (18) 18
research (17) 17
carboplatin (16) 16
medicine & public health (16) 16
mutation (16) 16
nivolumab (16) 16
antineoplastic combined chemotherapy protocols - adverse effects (15) 15
survival (15) 15
hematology, oncology and palliative medicine (14) 14
analysis (13) 13
carcinoma, non-small-cell lung - pathology (12) 12
combination (12) 12
gefitinib (12) 12
medicine, general & internal (12) 12
mice (12) 12
neoplasm staging (12) 12
non-small-cell lung cancer (12) 12
pathology (12) 12
patients (12) 12
trial (12) 12
antineoplastic agents - adverse effects (11) 11
antineoplastic agents - therapeutic use (11) 11
clinical trials (11) 11
japan (11) 11
genetic aspects (10) 10
health aspects (10) 10
lung cancer, small cell (10) 10
metastasis (10) 10
open-label (10) 10
pharmacology & pharmacy (10) 10
apoptosis (9) 9
cancer therapies (9) 9
carboplatin - administration & dosage (9) 9
cisplatin - administration & dosage (9) 9
erlotinib (9) 9
gemcitabine (9) 9
kaplan-meier estimate (9) 9
neurosciences (9) 9
non-small cell lung carcinoma (9) 9
nsclc (9) 9
original (9) 9
respiratory system (9) 9
retrospective studies (9) 9
survival rate (9) 9
tumors (9) 9
alzheimers-disease (8) 8
development and progression (8) 8
medical prognosis (8) 8
paclitaxel (8) 8
safety (8) 8
usage (8) 8
vinorelbine (8) 8
1st-line treatment (7) 7
adenocarcinoma (7) 7
alzheimer's disease (7) 7
bevacizumab (7) 7
brain (7) 7
carcinoma, non-small-cell lung - genetics (7) 7
double-blind (7) 7
drug combinations (7) 7
efficacy (7) 7
expression (7) 7
lung diseases (7) 7
lung neoplasms - genetics (7) 7
multicenter (7) 7
oncology, experimental (7) 7
phase-iii (7) 7
risk factors (7) 7
studies (7) 7
carcinoma, squamous cell - drug therapy (6) 6
cells (6) 6
emergency medicine (6) 6
etoposide (6) 6
inflammation (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Urology Supplements, ISSN 1569-9056, 03/2018, Volume 17, Issue 2, pp. e1488 - e1489
Journal Article
European Urology Supplements, ISSN 1569-9056, 03/2018, Volume 17, Issue 2, pp. e1261 - e1262
Journal Article
by Garassino, Marina Chiara and Cho, Byoung-Chul and Kim, Dong-Wan and Kim, Joo-Hang and Kim, Sang-We and Kim, Young-Chul and Mazières, Julien and Vansteenkiste, Johan and Lena, Hervé and Corral Jaime, Jesus and Gray, Jhanelle E and Powderly, John and Chouaid, Christos and Bidoli, Paolo and Wheatley-Price, Paul and Park, Keunchil and Soo, Ross A and Huang, Yifan and Wadsworth, Catherine and Dennis, Phillip A and Rizvi, Naiyer A and Paz-Ares Rodriguez, Luis and Novello, Silvia and Hiret, Sandrine and Schmid, Peter and Laack, Eckart and Califano, Raffaele and Maemondo, Makoto and Chaft, Jamie and Vicente Baz, David and Berghmans, Thierry and Surmont, Veerle and Reck, Martin and Han, Ji-Youn and Holgado Martin, Esther and Belda Iniesta, Cristobal and Oe, Yuichiro and Chella, Antonio and Chopra, Akhil and Robinet, Gilles and Soto Parra, Hector and Thomas, Michael and Cheema, Parneet and Katakami, Nobuyuki and Su, Wu-Chou and Wolf, Juergen and Lee, Jong-Seok and Saka, Hideo and Milella, Michele and Ramos Garcia, Inmaculada and Sibille, Anne and Yokoi, Takashi and Kang, Eun Joo and Atagi, Shinji and Spaeth-Schwalbe, Ernst and Nishio, Makoto and Imamura, Fumio and Gabrail, Nashat and Veillon, Remi and Derijcke, Sofie and Maeda, Tadashi and Zylla, Dylan and Kubiak, Kendra and Santoro, Armando and Uy, Ma. Noemi and Lucien Geater, Sarayut and Italiano, Antoine and Kowalski, Dariusz and Barlesi, Fabrice and Chen, Yuh-Min and Spigel, David and Chewaskulyong, Busyamas and Garcia Gomez, Ramon and Alvarez Alvarez, Rosa and Yang, Chih-Hsin and Hsia, Te-Chun and Denis, Fabrice and Sakai, Hiroshi and Vincent, Mark and Goto, Koichi and Bosch-Barrera, Joaquim and Weiss, Glen and Canon, Jean-Luc and Scholz, Christian and Aglietta, Massimo and Kemmotsu, Hirotsugu and Azuma, Koichi and Bradbury, Penelope and Feld, Ronald and Chachoua, Abraham and Jassem, Jacek and Juergens, Rosalyn and Palmero Sanchez, Ramon and Malcolm, Albert and Vrindavanam, Nandagopal and Kubota, Kaoru and Waller, Cornelius and Waterhouse, David and Coudert, Bruno and Mark, Zsuzsanna and ... and ATLANTIC Investigators
The Lancet Oncology, ISSN 1470-2045, 04/2018, Volume 19, Issue 4, pp. 521 - 536
Immune checkpoint inhibitors are a new standard of care for patients with advanced non-small-cell lung cancer (NSCLC) without tyrosine kinase or anaplastic... 
MULTICENTER | METAANALYSIS | NSCLC | ONCOLOGY | RANDOMIZED CONTROLLED-TRIAL | ATEZOLIZUMAB | IMMUNE CHECKPOINT | NIVOLUMAB | MEDI4736 | CLINICAL ACTIVITY | DOCETAXEL | Lung cancer, Non-small cell | Care and treatment
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2011, Volume 48, Issue 5, pp. 672 - 677
Journal Article
Journal Article
Annals of Oncology, ISSN 0923-7534, 10/2018, Volume 29, Issue suppl_8
Journal Article
Cancer Science, ISSN 1347-9032, 05/2017, Volume 108, Issue 5, pp. 1000 - 1006
Journal Article
Annals of Oncology, ISSN 0923-7534, 10/2019, Volume 30, Issue Supplement_5
Abstract Background Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) improve the prognosis of EGFR-mutant non-small cell lung cancer... 
Journal Article
Journal of Animal Science, ISSN 0021-8812, 05/2017, Volume 95, Issue 5, p. 1900
The semen production traits of bulls from 2 major cattle breeds in Japan, Holstein and Japanese Black, were analyzed comprehensively using genome-wide markers.... 
Parameter estimation | Melting | Sperm | Semen | Genomes | Thawing | Environmental effects | Freezing | Body fluids | Seasonal variations | Cattle | Breeding success | Genetic analysis | Genetics | Inbreeding | Environment | Trends | Viability | Freeze-thawing | Age
Journal Article
Journal of Animal Science, ISSN 0021-8812, 05/2017, Volume 95, Issue 5, pp. 1900 - 1912
Journal Article
Anticancer Research, ISSN 0250-7005, 10/2017, Volume 37, Issue 10, pp. 5857 - 5862
Journal Article
Annals of Oncology, ISSN 0923-7534, 09/2019
Abstract Background Primary analysis of the phase III study WJTOG 3405 demonstrated superiority of progression-free survival (PFS) for gefitinib (G) in... 
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 01/2015, Volume 191, p. 1
Journal Article
ANTICANCER RESEARCH, ISSN 0250-7005, 07/2019, Volume 39, Issue 7, pp. 3923 - 3929
Background/Aim: Treatment with EGFR-tyrosine kinase inhibitor (TKI) shows a durable response against NSCLC harboring EGFR mutation; however, treatment... 
1ST-LINE TREATMENT | GEFITINIB | MULTICENTER | SENSITIVITY | T790M | OPEN-LABEL | CHEMOTHERAPY | EGFR mutation | CELL LUNG-CANCER | EVOLUTION | Afatinib | ONCOLOGY | sequential TKI-therapy | osimertinib | MUTATION | INHIBITORS | Tyrosine | Heterogeneity | Epidermal growth factor receptors | Non-small cell lung carcinoma | Mutation | Gefitinib | Kinases | Patients | Protein-tyrosine kinase
Journal Article